QGN-63771-38640
2 vaccinations
1 coded response
1 check-in
1 free-text entry
0 call cases
- Sex
- Female
- Age at first dose
- 26-30
- ZIP prefix
- 268 / WV
- Registered
- 2021-12-20
- Relationship
- Self
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2021-11-12
Dose 1 — Moderna
-
2021-12-10
Dose 2 — Moderna
-
2021-12-20
Registered in v-safe
-
2021-12-20
Survey response — day 7, dose 2MedDRA: Dizziness, Dyspnoea, Heart rate increased, Palpitations — Feeling: Fair · Site: Pain, Redness, Swelling, Itching · Chills, Headache, Joint pains, Muscle or body aches, Fatigue or tiredness, Nausea · Be unable to work or attend schoolFree text: shortness of breath, elevated heart rate, palpitations, dizzinessMedDRA releases: 2024-11 · check-in free text available
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-11-12 | Moderna | No |
| 2 | 2021-12-10 | Moderna | No |
Free text
Release 10 — day 7, dose 2
Systemic reaction (other): shortness of breath, elevated heart rate, palpitations, dizziness
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SRO | Dizziness | · | · | ✓ |
| SRO | Dyspnoea | · | · | ✓ |
| SRO | Heart rate increased | · | · | ✓ |
| SRO | Palpitations | · | · | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release